Panacea Acquisition Ii's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Panacea Acquisition Ii (PANA) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Peer Data As of Q4 2022
Competitors Tracked
-
Peer Group Market Share
100.00 %
Revenue Growth Y/Y
-
Net Margin
84.79 %
Key Findings: Panacea Acquisition Ii vs Its Competitors
- TTM: Trailing 12-month revenue of 2M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+142.4% annualized vs trailing 12 months).
- Peer revenue share: Panacea Acquisition Ii accounted for 100.0% of combined revenue among its tracked peer group.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
PANA Sales vs. its Competitors, Q4 2022
Panacea Acquisition Ii generated 100.00 % of the combined sales of its peer group.
PANA Stock Performance relative to its Competitors
PANA
Competitors (weighted)
Percent change over the selected range
